DAO vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

DAO

31.2
AI Score
VS
UTI Wins

UTI

45.4
AI Score

Investment Advisor Scores

DAO

31score
Recommendation
EXTENDED

UTI

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DAO UTI Winner
Forward P/E 0 27.248 Tie
PEG Ratio 0 1.8142 Tie
Revenue Growth 3.5% 7.2% UTI
Earnings Growth -50.0% -78.9% DAO
Tradestie Score 31.2/100 45.4/100 UTI
Profit Margin 2.7% 3.9% UTI
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

DAO 1M: +32.4% · 3M: +26.0% UTI 1M: +6.1% · 3M: -42.7%

Current Technical Phase

DAO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 67

RSI (14): 67.4 · Price: $19.35

UTI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.4 · Price: $21.66

Fundamentals Snapshot

Metric DAO UTI
Market Cap — —
Forward P/E 6.6 29.5
Trailing P/E 97.4 34.1
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.5% 0.6%
Operating Margin 0.1% 0.0%
EPS 0.19 0.61
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.